Results 151 to 160 of about 70,263 (258)

A phase 1 evaluation of inhaled oxytocin: Physiologically‐based pharmacokinetic model informed dosing of a novel heat‐stable oxytocin delivery system

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2672-2681, August 2026.
Aim To develop and validate a physiologically‐based pharmacokinetic (PBPK) model enabling inhaled oxytocin dose selection for clinical evaluation. Subsequently, to conduct a phase 1 study investigating the pharmacokinetics and safety of selected doses of an optimized inhaled oxytocin product in healthy, non‐pregnant female participants.
Pete Lambert   +6 more
wiley   +1 more source

Examining Referral Pathways for Patients with Hematuria: A Real-World Retrospective Analysis. [PDF]

open access: yesGlomerular Dis
Chang AR   +6 more
europepmc   +1 more source

Predictive Value of FT3/FT4 and Neutrophil‐to‐Lymphocyte Ratios for Post‐Ischemic Stroke Urinary Tract Infection and Their Association With Longitudinal Functional Recovery Trajectories: A Retrospective Cohort Study

open access: yesBrain and Behavior, Volume 16, Issue 8, August 2026.
This graphical abstract illustrates how acute ischemic stroke may be accompanied by neuroendocrine‐immune dysregulation, represented by a low FT3/FT4 ratio and a high neutrophil‐to‐lymphocyte ratio, which together improve early identification of patients at risk for post‐ischemic stroke urinary tract infection.
Zhangyan Geng   +8 more
wiley   +1 more source

The Unusual Coexistence of Chronic Lymphocytic Leukemia, Dengue Fever, and Acute Kidney Injury: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT A 70‐year‐old male with CLL presented with dengue fever complicated by AKI. A diagnostic challenge arose from overlapping features. Investigations showed leukocytosis, lymphocytosis, anemia, thrombocytopenia, positive Anti‐Dengue IgM, and renal impairment. Managed with supportive care, ibrutinib, and monitoring, with improvement.
Musawer Khan   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy